My First Letter to My Future Self: My Current Holdings and Investment Plans

In the past, I’d say: 'The management team at Gree is definitely better at making money than I am—rest assured!' Now, after over a year in the stock market—having witnessed systemic risks, sector-specific risks, and company-level risks—I no longer dare claim with certainty that I’ll make money. Still, I actively seek to mitigate risk through individual stock analysis and portfolio diversification. The risk of *not* investing lies in inflation: watching the purchasing power of my hard-earned money erode day by day is unbearable to me. Investing in the stock market is thus a decision I’ve made after carefully weighing pros and cons. There’s a line from the film *High & Low*: 'People never stop moving—they simply advance in the direction they believe is right…' Even if I fail, it’s still worth fighting for. Because if I succeed, I won’t lack money; I’ll have love, true friends, the ability to care for my family—and even the luxury of seeking fame and reputation. My current holdings: First: Huadong Medicine — ROE above 15% for the past five years. — Core products: Bailin Capsules and Acarbose. To demystify pharmaceutical stocks, I went to a local pharmacy and asked whether they carried Acarbose. The clerk replied, 'Yes,' and pulled out a box of Acarbose. 'How much?' I asked. '¥41,' she said, retrieving a small box from a cabinet. I scrutinized the brand name closely—and spotted 'Zhongmei Huadong.' My heart leapt with joy: a listed company whose product reaches even small county towns is unlikely to be poor quality. Then I said, 'I’ll come back later to buy it.' Awkwardly turning on my heel, I strode off—leaving behind a dashing silhouette (though truthfully, I was skipping giddily, one step, three hops). I’m truly grateful for my own thick-skinned audacity—just asking, not buying! Second: Enhua Pharmaceutical — Also boasts ROE above 15% over the past five years. I bought in when the stock hit its daily limit-down—because I saw the actual controller buying shares himself. So I followed suit. (I bought only a small amount—I forget now whether it was the actual controller or a senior executive.) Third: Jin Tang Lang (Golden Swallow) — Industry leader in architectural decoration. — ROE above 15% for the past five years. — Accounts receivable growth has remained below revenue growth. Within its industry, Jin Tang Lang can easily take on thirty competitors at once. However, due to bribery scandals, Zhu Xingliang—the company’s actual controller—was investigated and ultimately arrested. During those two years, the company’s growth rate plummeted from 32% down to 12%, and by 2015 had turned negative at −9.8%. After his release, growth rebounded: +5.07% in 2016, +7.12% in 2017, and +19.49% in 2018. Jin Tang Lang has also expanded into the home renovation segment—and within three years, surpassed Dongyi Risheng, the former market leader in that space. According to corporate strategy, home renovation is slated to account for 50% of group revenue going forward—a healthier, more balanced business model. Recently, a Jin Tang Lang executive was arrested for bribery, causing a temporary stock dip. At the time, I noticed Zhu Xingliang had personally invested ¥100 million in Jin Tang Lang shares—so I bought in too, confident in his exceptional capabilities (a man who can take on ten others single-handedly). The industry offers enormous total addressable market, yet remains highly fragmented and fiercely competitive. Jin Tang Lang stands a strong chance of survival—but it’s relatively high-risk, reflected in its modest market valuation. Fourth: Yanghe Shares — Selling Gree to buy Yanghe remains my eternal regret—ha ha, such naive folly! — A top-tier growth stock among Chinese baijiu producers, ranked third nationally, yet trading at a lower valuation than peers. No further comment needed. Fifth: Nanjing Bank — ROE above 15% for the past five years. — Non-performing loan ratio consistently under 1% for eight years. — Provision coverage ratio exceeds 400%. — Dividend payout ratio ranks just below the Big Four state-owned banks—but offers the highest dividend yield among all banks. Will the bank’s net profit vanish next year? Will it stop paying dividends to shareholders?

Yinlu Network’s March 9, 2021 Financing Report

Big Data: 1. Shuming Technology completed a ¥100 million RMB Series A round, backed by Weilai Capital and Zeyue Capital. Shuming Technology operates under Shanghai Shuming Artificial Intelligence Technology Co., Ltd. Real Estate & Home Renovation: 1. Daleshuang Construction completed a multi-million-RMB angel round, funded by Orient Fuhai and Xianfeng Changqing. Daleshuang Construction operates under Shenzhen Daleshuang Construction Technology Co., Ltd. Intelligent Manufacturing: 1. Zhongneng United Digital Technology Co., Ltd. closed a Series C+ round, with investors including Wuxing Holding, Shibei Hi-Tech Park, and Yimei Investment. 2. Shenzhen Keda Intelligent Equipment Co., Ltd. raised ¥334 million RMB via IPO. Shenzhen Keda Intelligent Equipment Co., Ltd. is the parent entity. 3. Shen Guang ALight completed a multi-million-RMB angel round, backed by Fenli Capital, Tsinghua Tongfang’s Inspur Star Program, and Yiwei Capital. Shen Guang ALight operates under Beijing Shen Guang Technology Co., Ltd. 4. Guanghui Laser closed a Series C round nearing ¥200 million RMB, with investors including DT Capital, Jiaqiao Capital, and Nantong Industrial Investment Group. Guanghui Laser operates under Guanghui (Shanghai) Laser Technology Co., Ltd. Robotics: 1. Muyi Robotics secured a strategic investment nearing ¥100 million RMB, led by BlueRun Ventures and Deppon Logistics. Muyi Robotics operates under Shanghai Muyi Robotics Technology Co., Ltd. Automotive & Transportation: 1. YouDiu Secondhand Parts raised a multi-million-RMB Series A+ round, backed by NIO Capital.

Oil-Dri: Fiscal 2026 Revenue Reaches Record $493.8 Million As Net Income Hits $57 Million

4 days ago

Oil-Dri Corporation of America achieved record fiscal 2026 net sales of $493.8 million and net income of $57 million, driven by retail growth despite increased manufacturing costs.

Pulse 2.0

2026-03-25

Oil Dri declares $0.205 dividend

2026-03-25

Oil-Dri Q1 Earnings Decline Year-Over-Year Amid Tough Comparison Pressures

2026-04-03

Oil-Dri Updates Deferred Compensation Plan and Restricted Stock Agreements

2026-04-03

Oil-Dri Corporation of America Insiders Dispose Stock Amid Bearish Signals

2026-04-04

Oil-Dri Corporation Share Price Crosses Above 200-Day Moving Average